Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NHS England, NICE & Vertex Have ‘Forgotten Patients’ In Orkambi Impasse

Executive Summary

Vertex, NHS (National Health Service) England, and the health technology appraisal body NICE have forgotten about patients in the impasse over access to cystic fibrosis drug Orkambi, says a patient representative who attended the recent hearing on the price of the drug.

You may also be interested in...



UK Rare Disease Drug Review Reform Urged As Spinraza Finally Gets NICE OK

It has taken 17 months of negotiations but soon 600-1,200 people in the UK may be able to get Biogen's spinal muscular atrophy therapy now that an access agreement has been inked.

UK NICE To Pharma Firms: Up Your Game In Horizon Scanning

Pharmaceutical companies must play a fuller part in planning for health technology appraisals by NICE, which has resource limitations and cannot do everything that companies might expect of it, a recent workshop in London heard.

‘Extreme Outlier’ Vertex Slammed For Orkambi Pricing Approach In England

Vertex has come under fire for its alleged extreme rigidity on pricing for its cystic fibrosis drug in England.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS124909

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel